FDA Warns Chinese OTC Drugmaker

Drug Industry Daily
A A
The FDA hit Hangzhou Guogang Touring Commodity, an OTC drug manufacturer in Zhejiang, China, with a warning letter, for significant problems with equipment cleaning and drug product conformity.

To View This Article:

Login

Subscribe To Drug Industry Daily